CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Operating activities
Net loss	$ (189,253)	$ (101,879)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	7,750	5,238
Equity-based compensation	16,637	13,856
Change in fair value of warrants	5,701	33,177
Debt extinguishment loss	13,734
Issuance of common warrants	9,006
Change in fair value of derivative liability	77,184
Change in fair value of asset purchase agreement liability		(966)
Realized and unrealized gain on short term investments	(3,066)	(888)
Equity method investment (gain)loss	(58)	175
Asset retirement obligation accretion	104	76
Amortization of debt discount	9,566	6,174
Changes in operating assets and liabilities:
Accounts receivable	955	(969)
Other current assets	(231)	388
Other assets	167	110
Accounts payable	(197)	467
Deferred revenue	203	(9)
Accrued expenses and other liabilities	362	5,990
Operating lease right-of-use assets and liabilities	691	1,052
Net cash used in operating activities	(50,745)	(38,008)
Investing activities
Purchases of network assets, property, and equipment	(50)	(350)
Purchase of equity method investment	(550)
Purchase of internal use software	(424)	(442)
Purchase of marketable securities	(281,530)	(82,443)
Sale and maturity of marketable securities	218,000	46,500
Payment for asset purchase agreement liability		(2,732)
Net cash used in investing activities	(64,554)	(39,467)
Financing activities
Proceeds from 2028 senior convertible notes	190,000
Repayment of 2026 senior secured notes	(70,700)
Payments towards debt issuance cost	(1,517)
Payments towards debt	(116)	(111)
Proceeds from exercise of common stock options	1,957	3,787
Proceeds from exercise of common warrants	858	31,387
Redemption of non-controlling interests		40
Net cash provided by financing activities	120,482	35,103
Effect of exchange rates on cash and cash equivalents	244	(176)
Net increase (decrease) in cash and cash equivalents	5,427	(42,548)
Cash and cash equivalents at beginning of period	39,330	81,878
Cash and cash equivalents at end of period	44,757	39,330
Supplemental disclosures
Issuance of shares for asset purchase agreement	20,394
Issuance of warrants	9,006
Interest paid in cash	8,694	3,502
Reclassification of warrant liability to common stock warrants	1,241	11,523
Income taxes paid, net	186	195
Interest paid in shares		$ 3,842